Certified by Founder Lodge
Wellington Management
United States - Boston, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $238,000,000
18 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
-
Website
https://www.wellington.com/en/about-us/why-wellington-management
- Contact
- Social Links
For almost 100 years, we have chosen to do things differently, including the way we structure our ownership model, organization, and investment platform. Critically, we know that the best inv
| Company | Date | Round | Raised |
|---|---|---|---|
 SeatGeek |
September, 01 ,2022 | Series E | $238,000,000 |
 FalconX |
June, 22 ,2022 | Series D | $150,000,000 |
 Arcadia |
May, 10 ,2022 | Series E | $200,000,000 |
 Xepelin |
May, 05 ,2022 | Series B | $111,000,000 |
 CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
 SPAN |
March, 22 ,2022 | Series B | $90,000,000 |
 Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
 Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
 HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
 Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
 AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
dezerv.
Kristal.AI
Finary
Savart
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
